PCR Biosystems has launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product. RiboShield™ RNase Inhibitor is a recombinant protein that blocks the activity of a wide range of ribonucleases to reliably protect RNA from RNase digestion. The inhibitor is designed for use in a variety of RNA-sensitive applications including RNA purification, cDNA synthesis, RT-PCR, RNA sequencing, and in-situ hybridization....
Kallik, a leading labelling and artwork management solution provider for regulated markets, has announced it has joined the life sciences organisation Medilink West Midlands, an industry association dedicated to supporting growth of this key market sector throughout the region. The new agreement expands the existing Kallik patronage of Medilink East Midlands to the whole of the Midlands, and will provide close ties with members of over 1,700 life sciences organisations....
Bruker Corporation has announced its support of a worldwide collaborative project that investigates the structures, dynamics, function and binding of SARS-CoV-2 viral RNA and proteins using high-field nuclear magnetic resonance (NMR) spectroscopy. The Covid19-NMR consortium was initiated at Goethe University (GU) in Frankfurt, Germany, and leverages the extensive experience of the GU Biological Magnetic Resonance Center and of 30 consortium groups in 15 countries in high-field NMR, structural biology, and small molecule drug screening.
Researchers and clinicians in Glasgow will lead a global study into the long-term health impacts of COVID-19. The international, multi-site study is launched by ISARIC to measure prevalence and risk factors of long-term health and psychosocial consequences of COVID-19. The researchers are inviting hospitals and healthcare sites worldwide to join this new study. The ISARIC Global COVID-19 follow-up working group is led by Dr Janet Scott, of the MRC-University of Glasgow’s Centre for Virus Research...
Teknova, a leading manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, has responded quickly to the global COVID-19 pandemic by significantly scaling up production of Viral Transport Medium (VTM) and saline. All Teknova VTM is manufactured and validated according to the CDC procedure, and both VTM and saline are manufactured under GMP conditions in compliance with ISO 13485 standards and the Quality System Regulations under 21 CFR Part 820....
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19. Enzyme linked immunosorbent assays (“ELISAs”) are very common research tools used to detect and quantify a target of interest in a wide range of samples....
AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests that can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes. The tests utilize AnteoTech’s patented AnteoBind™ activated europium technology and provide significantly higher sensitivity than that offered by currently available COVID-19 tests....
Steam sterilization in autoclaves is used - especially in biological and medical laboratories - to inactivate natural or genetically modified microorganisms. However, during the heat-up phase, in which air is removed from the pressure vessel, biological agents can potentially escape into the work area as aerosols.This means that exhaust air filtration is extremely important, especially in light of the current coronavirus epidemic....
Porvair Sciences announces a special version of its popular Homogeniser Spin Column optimised for RNA extraction from buccal swabs. A large number of current COVID-19 diagnostic tests are reliant on detection of viral RNA from buccal swabs by PCR. The Chromatrap® Homogeniser Spin Column from Porvair Sciences has been adapted to ensure that it can routinely improve yield and quality of viral RNA from nasal and throat swab samples.,,
iST Scientific, one of the UK’s leading laboratory equipment suppliers to the life sciences industry, announces that it has supplied 5.2 million specialist micro-plate sealing films, which are vital components in Covid-19 tests, across the globe. This figure equates to over half a billion individual wells being used throughout the PCR process internationally.
Agilent Technologies Inc. has announced it will expand its state-of-the-art production facility in Frederick, Colorado, that develops and manufactures “oligos,” which are short DNA and RNA molecules used to create nucleic acid-based therapeutics. Oligos hold the potential to be used in developing treatments for cancer, COVID-19, cardiovascular disease, rare and infectious diseases, and other conditions....
COVID-19 remains in the forefront for all of us. Pall Laboratory’s solutions continue to help researchers around the globe. Offering filtration solutions for applications such as Waste water testing, Viral RNA isolation, Sterile filtration of media, reagents and kits and Viral protein concentration. Pall Laboratory has a complete line-up of filtration products for all size workflow needs such as Tangential Flow Filtration (TFF), syringe filters, centrifugal devices, filter microplates, capsules, air/gas filters, vacuum devices, membrane discs, filter holders, and more....
While it is well recognised that the risk of a severe COVID-19 infection is linked to certain long-term health conditions, little is known, so far, about the effects of multimorbidity and polypharmacy (taking multiple medications) on the risk of a serious coronavirus infection. Now, a new study led by the University of Glasgow and published in PLOS ONE, is the first to link both multimorbidity and polypharmacy with the risk of having a positive COVID-19 test....
Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has announced the availability of a highly accurate assay for simultaneously measuring the concentration and binding of IgG, IgM, and IgA antibodies to the Receptor Binding Domain (RBD) of SARS-CoV-2. Carterra’s new label-free assay provides, for the first time, detailed resolution of the immune response of patients recovering from COVID-19 in a single assay...
Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Ingenza has been working closely with researchers at Oxford University and the UK CPI, Wilton, since the start of the outbreak, and the collaboration is continuing to make excellent progress...
Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, has announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19. The antibodies, originally generated by Fred Hutchinson Cancer Research Center, have been engineered into recombinant formats useful for COVID-19 research and diagnostic development....
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that its Hand Sanitizer Analyzer instrument can be used to test for the presence of methanol in alcohol-based hand sanitizer products with pass/fail results delivered in 30 seconds or less. Recent warnings and recalls from the FDA indicate that methanol can be toxic to consumers if absorbed through the skin and life threatening if ingested...
IBMS Council delivers a position statement on the need for accreditation and registered staff in all laboratories doing COVID-19 testing. The national response to the COVID-19 pandemic has required an unprecedented increase in the UK’s capacity to provide timely and accurate testing for the SARS-CoV-2 virus. The Institute of Biomedical Science (IBMS) supports the UK government strategy to control the virus by increasing testing numbers and by implementing the test, track and trace programme....
More than 305,000 high-resolution, multi-channel COVID-19 cellular images captured in less than four weeks with Molecular Devices ImageXpress® Micro Confocal High-Content Imaging System are now available to the scientific community. With the COVID-19 pandemic impacting millions around the globe, researchers are racing to develop a vaccine or drug treatment. In an effort to better understand the cellular responses to COVID-19, the digital biology company Recursion has publicly released the world’s largest imaging dataset....
Intravacc and the Celonic Group has announced that they have signed a research agreement to further design, develop and produce a Covid-19 vaccine based on an immunogenic Spike (S) protein of SARS-CoV-2 combined with Intravacc’s prorietary Outer Membrane Vesicle (OMV) technology. In the beginning of March this year Intravacc started working on the development of four candidate coronavirus vaccines...
This year, in addition to the academic year course ‘Honors Computational Medicinal Chemistry’, 80 rising juniors and seniors will embark upon a special summer short-course entitled ‘Computing COVID-19’, utilizing StarDrop in conjunction with other bioinformatics tools. Optibrium’s lead product, StarDrop, is a comprehensive suite of integrated software...
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with the Liverpool School of Tropical Medicine (“LSTM”) to clinically validate the rapid, saliva-based coronavirus antigen test that Avacta is developing with Cytiva. LSTM has been at the forefront of research into infectious, debilitating and disabling diseases since 1898....
PCR Biosystems has launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product. RiboShield™ RNase Inhibitor is a recombinant protein that blocks the activity of a wide range of ribonucleases to reliably protect RNA from RNase digestion. The inhibitor is designed for use in a variety of RNA-sensitive applications including RNA purification, cDNA synthesis, RT-PCR, RNA sequencing, and in-situ hybridization....
Kallik, a leading labelling and artwork management solution provider for regulated markets, has announced it has joined the life sciences organisation Medilink West Midlands, an industry association dedicated to supporting growth of this key market sector throughout the region. The new agreement expands the existing Kallik patronage of Medilink East Midlands to the whole of the Midlands, and will provide close ties with members of over 1,700 life sciences organisations....
Bruker Corporation has announced its support of a worldwide collaborative project that investigates the structures, dynamics, function and binding of SARS-CoV-2 viral RNA and proteins using high-field nuclear magnetic resonance (NMR) spectroscopy. The Covid19-NMR consortium was initiated at Goethe University (GU) in Frankfurt, Germany, and leverages the extensive experience of the GU Biological Magnetic Resonance Center and of 30 consortium groups in 15 countries in high-field NMR, structural biology, and small molecule drug screening.
Researchers and clinicians in Glasgow will lead a global study into the long-term health impacts of COVID-19. The international, multi-site study is launched by ISARIC to measure prevalence and risk factors of long-term health and psychosocial consequences of COVID-19. The researchers are inviting hospitals and healthcare sites worldwide to join this new study. The ISARIC Global COVID-19 follow-up working group is led by Dr Janet Scott, of the MRC-University of Glasgow’s Centre for Virus Research...
Teknova, a leading manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, has responded quickly to the global COVID-19 pandemic by significantly scaling up production of Viral Transport Medium (VTM) and saline. All Teknova VTM is manufactured and validated according to the CDC procedure, and both VTM and saline are manufactured under GMP conditions in compliance with ISO 13485 standards and the Quality System Regulations under 21 CFR Part 820....
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19. Enzyme linked immunosorbent assays (“ELISAs”) are very common research tools used to detect and quantify a target of interest in a wide range of samples....
AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests that can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes. The tests utilize AnteoTech’s patented AnteoBind™ activated europium technology and provide significantly higher sensitivity than that offered by currently available COVID-19 tests....
Steam sterilization in autoclaves is used - especially in biological and medical laboratories - to inactivate natural or genetically modified microorganisms. However, during the heat-up phase, in which air is removed from the pressure vessel, biological agents can potentially escape into the work area as aerosols.This means that exhaust air filtration is extremely important, especially in light of the current coronavirus epidemic....
Porvair Sciences announces a special version of its popular Homogeniser Spin Column optimised for RNA extraction from buccal swabs. A large number of current COVID-19 diagnostic tests are reliant on detection of viral RNA from buccal swabs by PCR. The Chromatrap® Homogeniser Spin Column from Porvair Sciences has been adapted to ensure that it can routinely improve yield and quality of viral RNA from nasal and throat swab samples.,,
iST Scientific, one of the UK’s leading laboratory equipment suppliers to the life sciences industry, announces that it has supplied 5.2 million specialist micro-plate sealing films, which are vital components in Covid-19 tests, across the globe. This figure equates to over half a billion individual wells being used throughout the PCR process internationally.
Agilent Technologies Inc. has announced it will expand its state-of-the-art production facility in Frederick, Colorado, that develops and manufactures “oligos,” which are short DNA and RNA molecules used to create nucleic acid-based therapeutics. Oligos hold the potential to be used in developing treatments for cancer, COVID-19, cardiovascular disease, rare and infectious diseases, and other conditions....
COVID-19 remains in the forefront for all of us. Pall Laboratory’s solutions continue to help researchers around the globe. Offering filtration solutions for applications such as Waste water testing, Viral RNA isolation, Sterile filtration of media, reagents and kits and Viral protein concentration. Pall Laboratory has a complete line-up of filtration products for all size workflow needs such as Tangential Flow Filtration (TFF), syringe filters, centrifugal devices, filter microplates, capsules, air/gas filters, vacuum devices, membrane discs, filter holders, and more....
While it is well recognised that the risk of a severe COVID-19 infection is linked to certain long-term health conditions, little is known, so far, about the effects of multimorbidity and polypharmacy (taking multiple medications) on the risk of a serious coronavirus infection. Now, a new study led by the University of Glasgow and published in PLOS ONE, is the first to link both multimorbidity and polypharmacy with the risk of having a positive COVID-19 test....
Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has announced the availability of a highly accurate assay for simultaneously measuring the concentration and binding of IgG, IgM, and IgA antibodies to the Receptor Binding Domain (RBD) of SARS-CoV-2. Carterra’s new label-free assay provides, for the first time, detailed resolution of the immune response of patients recovering from COVID-19 in a single assay...
Edinburgh-based biotech company Ingenza Ltd. has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Ingenza has been working closely with researchers at Oxford University and the UK CPI, Wilton, since the start of the outbreak, and the collaboration is continuing to make excellent progress...
Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, has announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19. The antibodies, originally generated by Fred Hutchinson Cancer Research Center, have been engineered into recombinant formats useful for COVID-19 research and diagnostic development....
Intravacc and the Celonic Group has announced that they have signed a research agreement to further design, develop and produce a Covid-19 vaccine based on an immunogenic Spike (S) protein of SARS-CoV-2 combined with Intravacc’s prorietary Outer Membrane Vesicle (OMV) technology. In the beginning of March this year Intravacc started working on the development of four candidate coronavirus vaccines...
This year, in addition to the academic year course ‘Honors Computational Medicinal Chemistry’, 80 rising juniors and seniors will embark upon a special summer short-course entitled ‘Computing COVID-19’, utilizing StarDrop in conjunction with other bioinformatics tools. Optibrium’s lead product, StarDrop, is a comprehensive suite of integrated software...